Dr. Reddy's To Launch Generic Version Of Librax - Quick Facts
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the U.S. launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, a therapeutic equivalent generic version of Librax. Dr. Reddy's Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100.
The company noted that Librax brand and generic market had U.S. sales of approximately $105.9 million MAT for the most recent twelve months ending in July 2021.
Dr. Reddy's is an an integrated pharmaceutical company offering a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.